NASDAQ: ARXSArxis Inc Stock
$43.10-1.83 (-4.07%)
Updated Jun 1, 2026
ARXS Price
$43.10
Fair Value Price
N/A
Market Cap
$17.69B
52 Week Low
$33.15
52 Week High
$48.68
P/E
N/A
P/B
5.56x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.09
Operating Cash Flow
N/A
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ARXS Overview
Arxis, Inc. designs and manufactures electronic and mechanical components for mission critical applications in the United States. It provides engineered components used in high performance and extreme operating environments, including connectors, cable assemblies, RF and microwave components, sensors, bearings, and precision mechanical parts. It also offers solutions integrated into aerospace, defense, space, medical technology, semiconductor testing, industrial automation, and specialized industrial systems. It caters to defense and space programs, commercial aerospace platforms, medical technology manufacturers, semiconductor testing operations, and industrial technology sectors requiring engineered components for demanding use cases. The company was founded in 2019 and is based in Bloomfield, Connecticut.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARXS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ARXS news, forecast changes, insider trades & much more!
ARXS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARXS is good value based on its book value relative to its share price (5.56x), compared to the US Aerospace & Defense industry average (7.31x)
P/B vs Industry Valuation
ARXS's short-term assets ($943.95M) exceed its short-term liabilities ($255.17M)
Short-term Liabilities Financials
ARXS's long-term liabilities ($3.20B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more ARXS due diligence checks available for Premium users.
Valuation
ARXS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.56x
Industry
7.31x
ARXS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARXS's financial health
Profit margin
Revenue
$458.9M
Net Income
$53.3M
Profit Margin
11.6%
Assets to liabilities
Assets
$6.6B
Liabilities
$3.5B
Debt to equity
1.09
ARXS's short-term assets ($943.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARXS's long-term liabilities ($3.20B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$36.5M
Investing
-$80.5M
Financing
$33.5M
ARXS vs Defense Stocks
Arxis Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.